ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
53.35
-0.91 (-1.68%)
Dec 20, 2024, 4:00 PM EST - Market closed
ANI Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 1,042 | 1,052 | 656 | 771 | 348 | 733 | Upgrade
|
Market Cap Growth | 6.12% | 60.42% | -14.98% | 121.46% | -52.48% | 38.82% | Upgrade
|
Enterprise Value | 1,521 | 1,175 | 913 | 966 | 535 | 868 | Upgrade
|
Last Close Price | 53.35 | 55.14 | 40.23 | 46.08 | 29.04 | 61.67 | Upgrade
|
PE Ratio | - | 67.99 | - | - | - | 122.23 | Upgrade
|
Forward PE | 10.20 | 14.04 | 14.79 | 12.86 | 7.15 | 13.32 | Upgrade
|
PS Ratio | 1.85 | 2.16 | 2.07 | 3.57 | 1.67 | 3.55 | Upgrade
|
PB Ratio | 2.57 | 2.30 | 1.94 | 2.15 | 1.78 | 3.44 | Upgrade
|
P/TBV Ratio | - | 5.38 | 19.39 | 64.94 | 96.52 | 25.43 | Upgrade
|
P/FCF Ratio | 13.57 | 9.56 | - | 1008.43 | 38.15 | 18.80 | Upgrade
|
P/OCF Ratio | 11.21 | 8.85 | - | 232.22 | 22.82 | 16.06 | Upgrade
|
PEG Ratio | 0.40 | 0.40 | 1.11 | 1.02 | - | 6.06 | Upgrade
|
EV/Sales Ratio | 2.74 | 2.41 | 2.89 | 4.47 | 2.57 | 4.20 | Upgrade
|
EV/EBITDA Ratio | 18.52 | 10.75 | 18.78 | 50.64 | 18.40 | 14.22 | Upgrade
|
EV/EBIT Ratio | 69.76 | 23.73 | - | - | - | 52.86 | Upgrade
|
EV/FCF Ratio | 19.81 | 10.67 | - | 1263.31 | 58.56 | 22.26 | Upgrade
|
Debt / Equity Ratio | 1.47 | 0.64 | 0.85 | 0.80 | 1.02 | 0.90 | Upgrade
|
Debt / EBITDA Ratio | 7.41 | 2.61 | 5.81 | 15.06 | 6.87 | 3.14 | Upgrade
|
Debt / FCF Ratio | 8.24 | 2.65 | - | 375.65 | 21.88 | 4.92 | Upgrade
|
Asset Turnover | 0.51 | 0.58 | 0.41 | 0.35 | 0.45 | 0.47 | Upgrade
|
Inventory Turnover | 1.75 | 1.68 | 1.43 | 1.41 | 1.60 | 1.42 | Upgrade
|
Quick Ratio | 1.84 | 2.63 | 2.15 | 2.61 | 1.32 | 2.18 | Upgrade
|
Current Ratio | 2.74 | 3.57 | 3.46 | 3.68 | 2.17 | 3.04 | Upgrade
|
Return on Equity (ROE) | -1.60% | 4.72% | -13.74% | -15.37% | -11.04% | 2.97% | Upgrade
|
Return on Assets (ROA) | 1.25% | 3.72% | -0.90% | -2.86% | -2.12% | 2.31% | Upgrade
|
Return on Capital (ROIC) | 1.51% | 4.50% | -1.08% | -3.38% | -2.43% | 2.61% | Upgrade
|
Earnings Yield | -0.84% | 1.78% | -7.30% | -5.52% | -6.47% | 0.83% | Upgrade
|
FCF Yield | 7.37% | 10.46% | -6.11% | 0.10% | 2.62% | 5.32% | Upgrade
|
Payout Ratio | 0.00% | 8.65% | - | - | - | - | Upgrade
|
Buyback Yield / Dilution | -10.09% | -11.89% | -29.09% | -5.28% | 0.63% | -2.28% | Upgrade
|
Total Shareholder Return | -10.09% | -11.89% | -29.09% | -5.28% | 0.63% | -2.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.